{
    "nct_id": "NCT03318783",
    "official_title": "Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial",
    "inclusion_criteria": "1. Age > 18\n2. Head CT evidence of subarachnoid hemorrhage\n3. Digital subtraction cerebral angiography or CT angiogram documenting the presence of a cerebral aneurysm.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Symptom onset compatible with SAH of > 3 days prior to admission to OHSU\n2. Absence of an indwelling external ventricular drain\n3. Administration of any of the following inducers/inhibitors of CYP3A4: ritonavir, indinavir, nelfinavir, saquinavir, clarithromycin, telithromycin, chloramphenicol, ketoconazole, itraconazole, nefazodone, cobicistat or enzalutamide.\n4. Suspected or confirmed pregnancy\n5. Preexisting severe neurologic deficit or condition\n6. Chronic renal failure requiring dialysis\n7. Severe terminal disease with life expectancy <6 months\n8. Unable to read or understand written or spoken English or Spanish\n9. Refusal of informed consent",
    "miscellaneous_criteria": ""
}